These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25024129)

  • 61. Effect of atenolol or metoprolol on waking hour dynamics of the QT interval in myocardial infarction.
    Singh JP; Musialek P; Sleight P; Davey P; Marinho M; Hart G
    Am J Cardiol; 1998 Apr; 81(7):924-6. PubMed ID: 9555785
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
    Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
    Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Göteborg Metoprolol Trial: electrocardiographically estimated infarct size.
    Herlitz J; Ejdebäck J; Swedberg K; Waagstein F; Hjalmarson A
    Am J Cardiol; 1984 Jun; 53(13):22D-26D. PubMed ID: 6731324
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction.
    Hirschl MM; Wollmann CG; Erhart F; Brunner W; Pfeffel F; Gattermeier M; Steger F; Mayr H
    Crit Care Med; 2013 Jun; 41(6):1396-404. PubMed ID: 23528803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.
    Stone GW; Martin JL; de Boer MJ; Margheri M; Bramucci E; Blankenship JC; Metzger DC; Gibbons RJ; Lindsay BS; Weiner BH; Lansky AJ; Krucoff MW; Fahy M; Boscardin WJ;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):366-75. PubMed ID: 20031745
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of metoprolol treatment on a disintegrin metalloproteinase expression and extracellular matrix remodeling after myocardial infarction in rats.
    Zhao J; Qu XF; Zhao CY; Cao FL; Zhou T; Li WM; Huang YL
    Chin Med J (Engl); 2007 Sep; 120(17):1549-52. PubMed ID: 17908467
    [No Abstract]   [Full Text] [Related]  

  • 67. Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE).
    Edwards J; Goodman SG; Yan RT; Welsh RC; Kornder JM; Deyoung JP; Chauret D; Picard JP; Eagle KA; Yan AT
    Am Heart J; 2011 Feb; 161(2):291-7. PubMed ID: 21315211
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 70. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
    Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
    J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effects of a new positive inotropic agent, OPC-8212 in patients with effort angina--comparison with beta-blocker, metoprolol].
    Kinoshita H; Maruyama Y; Maehara K; Shimizu Y; Inoue K; Ito N; Takishima T; Takahashi T; San-ei ND
    Kokyu To Junkan; 1988 Nov; 36(11):1199-203. PubMed ID: 2907819
    [No Abstract]   [Full Text] [Related]  

  • 72. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Gupta T; Kolte D; Khera S; Harikrishnan P; Mujib M; Aronow WS; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107131
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1982 Apr; 24(608):43-4. PubMed ID: 6123072
    [No Abstract]   [Full Text] [Related]  

  • 74. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
    Dickerson LM; Carek PJ
    J Fam Pract; 2001 Aug; 50(8):652. PubMed ID: 11509153
    [No Abstract]   [Full Text] [Related]  

  • 76. Something old, something new: beta blockers and clopidogrel in acute myocardial infarction.
    Sabatine MS
    Lancet; 2005 Nov; 366(9497):1587-9. PubMed ID: 16271628
    [No Abstract]   [Full Text] [Related]  

  • 77. Reperfusion strategies in acute coronary syndromes.
    Bagai A; Dangas GD; Stone GW; Granger CB
    Circ Res; 2014 Jun; 114(12):1918-28. PubMed ID: 24902975
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical and prognostic value of therapy with contemporary beta-adrenoblockers in patients after myocardial infarction].
    Bichan NA; Bykova EF; Gorbatovskiĭ IaA; Pakhtusova NI; Mishchenko EP; Kotarova LV
    Kardiologiia; 2005; 45(5):51-2. PubMed ID: 16007052
    [No Abstract]   [Full Text] [Related]  

  • 79. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
    Husebye T; Eritsland J; Müller C; Sandvik L; Arnesen H; Seljeflot I; Mangschau A; Bjørnerheim R; Andersen GØ
    Eur J Heart Fail; 2013 May; 15(5):565-72. PubMed ID: 23288914
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Beta-receptor blockers after revascularization in coronary sclerosis].
    Osterziel KJ
    Dtsch Med Wochenschr; 1995 Sep; 120(37):1258-9. PubMed ID: 7671786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.